Background and aims The clinical course and responsiveness to antiviral treatments differs among hepatitis B virus (HBV) genotypes. However, the cause of these differences is unclear. In the present study, we compared mRNA expression profiles in human hepatocyte chimeric mice infected with HBV genotypes A and C.
genotype A-infected hepatocytes, 172 genes, including KRT23 and C10orf54, were significantly more highly expressed than in HBV genotype C-infected cells, whereas 10 genes, including SPX and IER3, were expressed at significantly lower levels. Genes associated with the p53 pathway and the inflammation mediated by chemokine and cytokine signaling pathway were more highly expressed in cells with HBV genotype A infection, whereas genes associated with CCKR signaling map and oxidative stress response were more highly expressed in cells with HBV genotype C infection. Conclusion Several differences in gene expression with respect to HBV genotype A and C infection were detected in human hepatocytes. These differences might be associated with genotypic difference in the clinical course or responsiveness to treatment. 
Introduction
Hepatitis B virus (HBV) is a member of the Hepadnaviridae family and carries a 3.2-kb partially doublestranded circular DNA genome within the viral particle. Although universal HBV vaccination has been promoted worldwide, more than 250 million people still have chronic HBV infection, and 887,000 individuals die annually from HBV-related liver diseases and their complications (http:// www.who.int/mediacentre/factsheets/fs204/en/). To reduce the number of cases of acute and chronic HBV infections, worldwide preventive programs for HBV infection from HBV-infected mother to children have been established, resulting in a drastic decrease in the number of chronic HBV carriers. However, incidence of acute hepatitis B has not been reduced sufficiently. Although more than 90% of chronic hepatitis B patients in Japan are infected with HBV genotype C, the number of acute hepatitis B patients infected with HBV genotype A has recently been increasing [1] [2] [3] . The characteristics of chronic hepatitis B, including the clinical course and responsiveness to antiviral treatments, differ among HBV genotypes. In acute HBV genotype A infection, serum HBV DNA levels in the early phase of acute infection are higher than in HBV genotype C infection, and prolongation of ALT elevation could be observed at comparatively lower levels [3] . However, the cause of the differences in clinical characteristics among HBV genotypes has not been determined.
Development of effective HBV treatments was long hindered by the lack of suitable animal models for HBV study. In 2001, Mercer and colleagues developed a chimeric mouse technique in which mouse hepatocytes are largely replaced with transplanted human primary hepatocytes, and they and others demonstrated that these human hepatocyte chimeric mice could be continuously infected with HBV [4, 5] . Because these mice were derived from severe combined immunodeficiency (SCID) mice, they lack an effective adaptive immune system, and their T and B cells are severely suppressed. This chimeric mouse model is useful for analyzing the response of human hepatocytes to viral infection without the confounding effects of the adaptive immune response as well as the low risk of rejection of the transplanted hepatocytes [6] [7] [8] . We previously performed cDNA microarray analysis using this mouse model and reported that HBV infection regulated expression of interferon-stimulated genes in human hepatocytes under immunodeficient conditions, suggesting that HBV proteins might confer the ability to evade or suppress the innate immune response in human hepatocytes [9] . However, cDNA microarray technology suffers from issues regarding accuracy and sensitivity, and the use of fixed probes based on predesigned oligonucleotides makes the system rigid and unsuitable for identifying novel transcripts or isoforms [10, 11] . Next-generation sequence analysis has been developed as an advanced system for genome-wide gene expression analysis that resolves many of these limitations [12] and could provide more accurate gene expression profiles.
In this study, we performed genome-wide gene expression analysis of human hepatocytes extracted from chimeric mouse livers infected with HBV genotype A or C to assess differences in the direct effects between HBV genotype A and C on intrahepatic gene expressions.
Materials and methods

Human serum samples
Serum samples were obtained from HBV carriers after obtaining written informed consent for the donation and evaluation of blood samples. The inocula used to infect mice were positive for HBs and HBe antigens with highlevel viremia (HBV genotype A: serum HBV DNA 6.8 log copies/ml; HBV genotype C: serum HBV DNA 7.8 log copies/ml) and had slightly elevated levels of serum alanine aminotransferase. The experimental protocol meets the ethical guidelines of the Declaration of Helsinki and was approved by the Hiroshima University Ethical Committee.
Human hepatocyte chimeric mouse experiments
Preparation of uPA ?/? /SCID ?/? mice and transplantation of human hepatocytes were performed as described previously [5] . All mice were transplanted with frozen human hepatocytes obtained from the same donor. All animal protocols described in this study were performed in accordance with the guidelines of the local committee for animal experiments at Hiroshima University and all animals received humane care.
Fifteen chimeric mice in which more than 90% of the liver tissue had been replaced by transplanted human hepatocytes were assigned to one of three experimental groups. Group 1 contained five mice that were not infected with HBV and acted as uninfected controls. The mice in groups 2 and 3 were inoculated via the mouse tail vein with human serum containing 1.0 9 10 6 copies of HBV genotype A or genotype C, respectively. After inoculation, we collected mouse sera every 2 weeks and analyzed HBV DNA titers by real-time PCR. After serum HBV DNA levels plateau at around 8 log copies/ml, all mice were killed. Infection, extraction of serum samples and killing of animals were performed under ether anesthesia. Human serum albumin in mouse serum was measured with a Human Albumin ELISA Quantitation kit (Bethyl Laboratories Inc., Montgomery, TX) according to the manufacturer's instructions. Serum samples obtained from mice were aliquoted and stored in liquid nitrogen prior to use.
Dissection of mouse livers and total RNA extraction from human hepatocytes in the mouse livers All 15 chimeric mice were killed by anesthesia with diethyl ether. Human hepatocytes from the mouse livers were finely dissected and stored in liquid nitrogen after submergence in RNAlater solution (Applied Biosystems, Foster City, CA). Total RNA was extracted by NucleoSpin RNA II (MACHEREY-NAGEL GmbH & Co. KG, Düren, Germany). Qualities of extracted RNA samples were verified by absorption analysis, electrophoresis and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).
Quantification of serum HBV markers
For quantitative analysis of HBV DNA, 10 ll of mouse serum was used. Serum HBV DNA was quantified by realtime PCR using the TaqMan PCR System (Roche Diagnostics, Tokyo, Japan). The lower quantitation limit of this assay is 4.4 log copies/ml. Serum HBsAg and HBeAg levels were measured using Abbott Architect platforms (Abbott, Diagnostic Division, Ireland) following the manufacturer's protocol.
Quantification of intrahepatic HBV DNA and cccDNA
DNA was extracted from 20 mg of mouse liver using the DNeasy blood and tissue kit (Qiagen, Hilden, Germany), and intrahepatic HBV DNA and cccDNA levels were quantified using an ABI Prism 7300 (Applied Biosystems, Carlsbad, CA, USA), as previously described [13] . Briefly, single-stranded DNA was selectively degraded from the extracted DNA using S1 nuclease (TakaraBio, Shiga, Japan), and then cccDNA levels were quantified using TaqMan gene expression master mix (Applied Biosystems) with forward primer (nucleotides [nt] 1521-1545) 5=GG GGCGCACCTCTCTTTACGCGGTC-3=, reverse primer (nt 1862-1886) 5=-CAAGGCACAGCTTGGAGGCTT GAAC-3 = , and TaqMan MGB probe (nt 1685-1704) 5-FAM-AACGACCGACCTTGAGGCAT-MGB-3. PCR was performed using 100 ng of extracted DNA, with a lower limit of detection of 100 copies/100 ng DNA.
Construction of sequence library
PolyA ? RNAs were extracted from the total RNA samples and fragmented. The fragmented polyA ? RNAs were linked with RNA 3 0 adapter. Reverse transcription was performed using a specific primer that recognizes RNA 3 0 adapter, and polymerase chain reaction was performed using single-stranded cDNA templates.
Next-generation sequencing and data analysis
Transcript expression profiles were obtained by next-generation sequencing using the HiSEQ 2000 platform (Illumina, Tokyo, Japan). Human transcript expression profiles were analyzed using Cufflinks 2.0.7 software (Takara Bio, Tokyo, Japan). Differential expression was analyzed by the Mann-Whitney U test with Benjamini-Hochberg correction (Q \ 0.05). Complete linkage hierarchical clustering analysis was applied using Cluster ver. 3.0 software.
Pathway analysis
Comparisons of canonical pathways were performed using PANTHER software (http://www.pantherdb.org/) and Ingenuity TM Pathway Analysis (IPA) 8.6 (Ingenuity TM Systems, CA, USA).
Western blotting
Intrahepatic proteins were extracted from the chimeric mouse livers using RIPA buffer containing protease inhibitor cocktail and electrophoresis was performed.
Immunoblotting was performed with the following primary and secondary antibodies. Mouse monoclonal anti-HBs antibody (1:500, Institute of Immunology, Co. LTD., Tokyo, Japan), mouse monoclonal anti-HBc antibody (1:500, Institute of Immunology), rabbit polyclonal antiWnt1 antibody (ab15251, 1:500, Abcam, Cambridge, UK), and mouse monoclonal anti-GAPDH antibody (1:10,000, Proteintech Group, Inc., Tokyo, Japan) were used as primary antibodies, and anti-mouse IgG HRP-linked antibody (1:3000, GE Health Care Japan, Tokyo, Japan) and antirabbit IgG HRP-linked antibody (1:3000, GE Health Care Japan) were used as secondary antibodies.
Measurement of intracellular oxidative stress
Intracellular oxidative stress was measured using OxiSelect TM Protein Carbonyl ELISA Kit (Cell Biolabs, Inc., San Diego, CA), following the manufacturer's protocol. Chimeric mouse liver tissues were homogenized with icecold PBS buffer including protease inhibitor. The homogenates were centrifuged at 13,0009g for 10 min at 4°C to remove nucleic acid precipitates. Then, 100 ll of the sample solution (10 lg/ml) was added to a 96-well microtiter protein binding plate and incubated at 4°C overnight. After incubation, the samples were washed with phosphate-buffered saline (PBS) three times. After adding 100 ll of DNPH working solution Kit (Cell Biolabs), the samples were incubated in the dark at 37°C for 45 min. The samples were then reacted with 100 ll of horseradish peroxidase-conjugated anti-DNPH antibody and HRPconjugated second antibody. After stopping the reaction, absorbance of each sample at 450 nm was read immediately on Mithras LB940 system (Berthold Japan, Tokyo, Japan). Duplicate measurements were performed for each sample.
Statistical analysis
Pairwise differences between groups were examined for statistical significance using the Student's t test. Statistical analysis was performed using SPSS ver. 17.0 (SPSS Inc., Chicago, IL). All P values less than 0.05 by two-tailed test were considered significant.
Results
HBV infection in the mouse liver
Serum HBV DNA levels in Group 2 (HBV genotype A-infected mice) reached a plateau at more than 8 log copies/ml at 20 weeks after inoculation, and levels in Group 3 (HBV genotype C-infected mice) reached a plateau at more than 8 log copies/ml at 8 weeks after inoculation. We killed these mice at plateau and collected human hepatocytes from the mouse liver tissues. Serum HBV DNA, HBsAg, and HBeAg levels in the mouse sera were measured at the time of killing. Mean HBV DNA levels in Groups 2 and 3 were 8.22 ± 0.07 and 9.99 ± 0.13 log copies/ml, respectively. Although serum HBV DNA and HBsAg levels in Group 3 were significantly higher than those in Group 2 (P = 1.1 9 10 -8 , P = 3.5 9 10 -6 , respectively) ( Figure S1A and S1B), HBeAg levels in Group 3 were significantly lower than those in Group 2 (P = 4.9 9 10 -4 ) ( Figure S1C ). On the other hand, the expressions of HBs and HBc proteins in the mice livers in Group 3 were higher than those in Group 2 ( Figure S1D ). Intracellular HBV cccDNA levels in the mouse livers of Group 3 were significantly higher than in Group 2 (P = 0.010) ( Figure S1E ).
Changes in gene expression with HBV infection
To analyze the effects of HBV infection in human hepatocytes, we compared the gene expression profiles between Group 1 (uninfected control mice) and Group 2 or 3 (mice infected with HBV genotype A or genotype C). Expression data for 34,688 genes was obtained by next-generation RNA sequencing. After screening by Mann-Whitney U test with Benjamini-Hochberg correction, 780 genes were found to be differentially expressed in HBV genotype A-infected mice relative to uninfected control mice, and 208 genes were found to be differentially expressed in HBV genotype C-infected mice. Of these, 451 and 201 transcripts were significantly up-regulated by HBV genotype A and C infection, respectively, and the remaining 329 and 7 transcripts were significantly down-regulated. The top 20 up-regulated genes with HBV genotype A and C infection are shown in Tables 1 and 2 , respectively. Several immune response genes such as chemokine (C-C motif) ligand 2 (CCL2), chemokine (C-X-C motif) ligand 1 (CXCL1) and interleukin 8 (IL-8), were significantly upregulated in both HBV genotype A-and C-infected mice. However, similar up-regulation of genes belonging to the HLA family was not observed in HBV genotype C-infected mice. To assess the influence of intracellular signaling pathways, pathway analysis was performed using PAN-THER software. Several shared pathways, such as inflammation mediated by chemokine and cytokine signaling, p53, and integrin signaling pathways, were found to be associated with HBV infection (Table 3) . Therefore, we concluded that similar but slightly different intracellular responses occurred in the livers of HBV genotype A-infected versus genotype C-infected mice.
Comparison of gene expression levels between HBV genotype A and C infection
To clarify differences in intracellular responses among HBV genotypes, expression levels of genes that were upregulated by HBV genotype A or C infection were compared. 326 genes, including LCN2 and LYZ, had significantly higher expression in HBV genotype A-infected hepatocytes than in HBV genotype C-infected cells, and 32 genes, e.g., CCL2, CXCL9 and CXCL10, had significantly lower expression levels (Fig. 1) . We performed PANTHER pathway analysis using genes that showed a differential response between HBV genotype A and C infection (Table 4) . Genes associated with the p53 pathway and the inflammation mediated by chemokine and cytokine signaling pathway were more highly expressed in cells infected with HBV genotype A, whereas genes associated with CCKR signaling map and oxidative stress response were more highly expressed in cells infected with HBV genotype C. 
Comparison of regulated canonical pathways between HBV genotype A and C infection
To confirm the differences in the intracellular responses among HBV genotypes, we also employed Ingenuity Pathway Analysis (IPA). As shown in Table 5 , similar pathways, such as hepatic fibrosis/hepatic stellate cell activation, granulocyte adhesion and diapedesis, were identified. However, the number of genes associated with each canonical pathway differed between HBV genotype A and C infection (Fig. 2) , suggesting that differences in HBV genotype-specific gene expression might be reflected in clinical features. Confirmation of the pathway analyses using the mouse livers
To confirm the results of pathway analysis, the activation or induction of several signaling pathways, such as oxidative stress and Wnt1 signaling, were compared. First, we measured intracellular oxidative stress levels by ELISA using the mouse livers and compared the 3 groups. Intracellular oxidative stress in Group 3 (HBV genotype C infection) was significantly higher than in Group 1 (without HBV infection) (P = 0.028) and was also marginally higher than in Group 2 (HBV genotype A infection) (P = 0.076) ( Figure S2) . Secondly, the expression of genes associated with Wnt signaling in the mouse livers was compared. As shown in Figure S3A , Wnt1 expression levels in Group 3 mouse livers were higher than in Group 2. Furthermore, the expression levels of Wnt signaling-related genes, such as LGR5 and b-catenin, in the livers of Group 3 were significantly higher than in Group 2 (P = 0.024, P = 0.012, respectively) ( Figure S3B and S3C) , and FRA1 expression in Group 3 was marginally higher than in Group 2 (P = 0.094) ( Figure S3D ). However, no significant difference in GLUL expression was observed between Groups 2 and 3 (P = 0.294) ( Figure S3E ). Therefore, these results indicate that infection with HBV genotype C, but not genotype A, could moderately activate Wnt signaling.
Discussion
We have previously demonstrated that the human hepatocyte chimeric mouse model can support HBV and hepatitis C virus infection for more than 24 weeks and have shown Fig. 1 Comparison of upregulation levels between HBV genotype A and C infection. The 358 genes that were upregulated by HBV genotype A and/or C infection were extracted and fold changes of each gene were compared. Fold changes were determined by comparing expression levels between uninfected control samples and HBV-infected samples Table 4 Comparison of specific pathways by HBV Gt A and Gt C infection that this mouse model is suitable for analyzing the effects of viral infection and drug responses under immunodeficient conditions [6, 14, 15] . In the present study, we performed next-generation sequencing using this mouse model and compared gene expression profiles in mice infected with two different HBV genotypes to compare the effects of HBV infection on gene expression in human hepatocytes.
To avoid contamination with mouse tissue, only human hepatocyte chimeric mice in which mouse liver tissue had been more than 90% replaced with human hepatocytes were used in this study. Nonetheless, liver tissue extracted from human hepatocyte chimeric mice includes small amounts of mouse-derived cells, such as interstitial cells, bile duct cells, and vascular cells. Although sequences that were clearly derived from mouse mRNA were excluded, mapping of next-generation sequencing data may be influenced by cross-hybridization with mouse mRNA in these liver samples because the human and mouse genomes have high homology. However, since a previous study demonstrated the feasibility of gene expression analysis in chimeric mice using a functional genomics approach [16] , mice without HBV infection were set up as negative controls and gene expression profiles were compared using fold changes from negative controls.
Previously, we performed cDNA microarray analysis using HBV genotype C-infected chimeric mouse livers [9] . Although the protocols for collecting human hepatocytes from HBV-infected human hepatocyte chimeric mouse livers were almost the same as in the present study, a different inoculum and a different clone of human hepatocytes were used in that experiment. Although genes with low expression levels or genes whose probe were not included in cDNA microarray, such as IL-8, CXCL1, and CCL2, could not be extracted by cDNA microarray analysis, up-regulation of several genes, such as CCL20 and TNFAIP8, could be observed in both cDNA and nextgeneration sequencing analyses. Furthermore, in both the previous and the current gene expression analyses, upregulation of canonical interferon-stimulated genes, such as Mx1, OAS1, and SOCS1, was not observed in HBV-infected mice. The results were similar to those of previous gene expression studies using HBV-infected chimpanzees in which it was concluded that HBV did not induce an intrahepatic innate immune response [17] .
To analyze the effects of HBV infection, gene expression profiles were compared between the uninfected control mice and mice with HBV genotype A or C infection. After statistical analysis, 780 and 208 genes were found to be significantly associated with HBV genotype A and C infection, respectively. Several cytokines and chemokines were up-regulated by both HBV genotype A and C infection (Tables 1 and 2) , and the regulated pathways were quite similar between HBV genotype A and C infection. As the inflammation mediated by chemokine and cytokine signaling pathway, the p53 pathway, and the integrin signaling pathway were observed in the top five pathways associated with HBV infection, we concluded that similar responses occurred in human hepatocytes following HBV infection regardless of HBV genotype. However, the clinical characteristics of patients with acute or chronic HBV genotype A and C infection differ widely, and we considered it important to identify genes that were differentially regulated in HBV genotype A versus C.
As shown in Table 4 , not only the p53 pathway, but also the oxidative stress response and Wnt signaling pathways were specifically up-regulated during HBV genotype C infection, revealing an increased risk for developing hepatocellular carcinoma (HCC). This is unsurprising, as untreated HBV patients are known to have an increased risk of HCC regardless of HBV genotype, and, in particular, patients with HBV genotypes C, D, or F have an even higher risk of HCC development compared to other genotypes [18] [19] [20] . Supportive results using human hepatocyte chimeric mice have also been reported previously [21] . Sugiyama et al. indicated that oxidative damage in the mouse livers with HBV genotype C2 infection was significantly higher than that with HBV genotype A2 infection. Since continuous oxidative stress and activation of the Wnt signaling pathway are well known to activate carcinogenesis [22] [23] [24] [25] , the results of the present study provide insight into the potential mechanisms underlying genotype-specific differences in the clinical characteristics of chronic HBV infection and suggest that the induction of oxidative stress and Wnt signal activation by HBV genotype C play an important role in hepatocarcinogenesis.
Although inflammatory cytokines and chemokines were significantly induced by both HBV genotypes, the induction levels of inflammatory cytokines and chemokines, such as CCL2, CXCL8, CXCL9 and CXCL10, by HBV genotype A infection was comparatively lower than by HBV genotype C infection (Tables 1 and 2 ). On the other hand, inflammation-related pathways, such as granulocyte adhesion and diapedesis and agranulocyte adhesion and diapedesis, were strongly induced by HBV genotype C infection rather than by HBV genotype A infection ( Table 5 and Fig. 2) . With respect to the clinical aspects of HBV infection, since ALT elevation by acute HBV genotype A infection is lower than by HBV genotype C infection, whereas prolongation of ALT elevation is usually observed in patients with HBV genotype A infection [3] , these results suggest that induction of immune responses was greater in HBV genotype C infection than genotype A infection.
This study has several limitations. The first limitation was the number of HBV clones used. Although it would be preferable to use several HBV clones representing each genotype to analyze gene expression, it is difficult to verify the reproducibility of gene expression analyses using other HBV clones or different lots of human hepatocytes within the limited number of mice that could be used in this study because several inter-individual differences can be observed even among mice transplanted with the same lot of human hepatocytes. Therefore, we focused on the reproducibility of gene expression and used one wellcharacterized inoculum for each HBV genotype. We note that this reduces our ability to generalize these results to other clones within the same HBV genotype. The second limitation was the method used for next-generation sequencing. Although the accuracy of gene expression analysis has improved markedly with the development of next-generation sequencing, it was difficult to perform gene expression without first performing RNA amplification in this study, which might influence gene expression profiles and prevented us from measuring expression of RNAs without a polyA tail.
In conclusion, gene expression profiles were compared between HBV genotype A-and C-infected human hepatocytes. Several differences in gene expression with respect to HBV genotype A and C infection were detected in human hepatocytes. These differences might be associated with genotype-specific differences in the clinical course or responsiveness to treatment.
